Synereca Pharmaceuticals Alternatives & Competitors
12 companies similar to Synereca Pharmaceuticals — Pioneering orally active drugs to rejuvenate antibiotic efficacy against lung, u...
Companies similar to Synereca Pharmaceuticals
Zikani Therapeutics
A new era in antibiotic treatment targeting resilient gram-negative bacteria, delivering a...
Prokaryotics, Inc.
Antibacterial discovery organization committed to bringing forth innovative therapeutics t...
Union, United States
Sealife PHARMA® GMBH
Pioneering breakthroughs in marine biochemistry to combat drug-resistant infections and ad...
Curza
Small molecule therapeutics R&D company focused on developing new drugs to combat antibiot...
Rival Readout
Competing with Synereca Pharmaceuticals? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Tetraphase Pharmaceuticals
Fighting against antimicrobial resistance is at the core of our technology and our people.
Watertown, United States
Protez Pharmaceuticals
Pioneering advanced antibiotics to combat hospital-based infections and bacterial resistan...
PerioTrap Pharmaceuticals GmbH
We develop new and selective treamtents for periodontitis.
Germany
Melinta Therapeutics
Unparalleled in Passion & Purpose
United States
Spero Therapeutics
Clinical-stage biotech company focused on rare diseases and diseases with high unmet need
Cambridge, United States
MerLion Pharmaceuticals GmbH
Researches and develops drugs based on natural products
Germany
Akthelia Pharmaceuticals
Modulating innate immunity to improve cancer therapy outcomes. .
Iceland
Biocidium Biopharmaceuticals
Clinical-stage biopharmaceutical company focused on novel antibiotics, antifungals, and tr...
Canada
About Synereca Pharmaceuticals
Synereca Pharmaceuticals is a biotechnology startup that focuses on the development of orally active drugs to enhance the efficacy of existing antibiotics. Founded in 2009 and based in Chapel Hill, North Carolina, the company's product line includes prototypic RecA inhibitors, targeting a wide range of pathogenic bacte...
Pharmaceuticals, Drug Development, Antibiotics, Infectious Diseases, Bacterial Infections, RecA Inhibitors, Pathogenic Bacteria, E. Coli, Lung Infections, Urinary Tract Infections, Skin Infections, Gram-positive Bacteria, Gram-negative Bacteria, Bactericidal Antibiotics
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Synereca Pharmaceuticals: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Synereca Pharmaceuticals on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
